Odette Cancer Program

Administrative Assistant: Carm Cacciato
Phone: 416-480-6733
Email: carm.cacciato@sunnybrook.ca

Education:

• MD, 2013, University of Alberta, Canada
• FRCPC, 2016, Internal Medicine, University of Toronto, Canada
• FRCPC, 2018, Medical Oncology, Queen’s University, Canada
• MSc, 2020, University of Toronto, Canada

Appointments and Affiliations:

• Affiliate Scientist, Evaluative Clinical Sciences, Odette Cancer Research, Sunnybrook Research Institute
• Medical Oncologist, Sunnybrook Health Sciences Centre
• Assistant Professor, Department of Medicine, University of Toronto

Research Foci:

• Decision-analytic modelling
• Health technology assessment
• Health services research

Research Summary:

Dr. Parmar’s academic interests are in health services research and health technology assessment. Dr. Parmar is particularly interested in the use of decision-analytic modelling and economic evaluations to critically appraise current and emerging technologies utilized in cancer care.

Selected Publications:

See current publications list on PubMed.

1. Grafham GK, Craddock KJ, Huang WY, Louie AV, Zhang LY, Hwang DM, Parmar A. Referred molecular testing as a barrier to optimal treatment decision making in metastatic non-small cell lung cancer: Experience at a tertiary academic institution in Canada. Cancer Med; 2024 Feb; 13(3):e6886
2. Parmar A, Lu B, Luo J, Chan KK. Real-world comparative effectiveness and safety of pembrolizumab for PD-L1>50% metastatic non-small cell lung cancer. Future Oncol; 2024 May 29:1-10.
3. Parmar A, Dai WF, Dionne F, Geirnart M, Denberg A, Ahuja T, Beca J, Bouchard S, Chambers C, Hunt MJ, Husereau D, Lungu E, McDonald V, Mercer RE, Mitera G, Munoz C, Naipaul R, Peacock S, Potashnik T, Tadrous M, Takhar P, Taylor M, Trudeau M, Wasney D, Gavura S, Chan KKW. Development of a multi-criteria decision analysis rating tool to prioritize real-world evidence questions for the Canadian Real-World Evidence for Value (CanREValue) Collaboration. Curr Oncol; 2023 Mar 28;30(4):3776-3786.
4. Parmar A, Eskander A, Sander B, Naimark D, Irish JC, Chan KKW. Impact of cancer surgery slow-downs on patient survival during the COVID-19 pandemic: a microsimulation modelling study. CMAJ; 2022 Mar 21;194(11):E408-E414.
5. Everest L, Blommaert S, Chu R, Chan KKW, Parmar A. Parametric survival extrapolations of early survival data in economic analysis: a pooled analysis validation study. Value in Health; 2022 Apr;25(4):622-629.